RecruitingPhase 2NCT05713877
Melatonin for Treatment of Delirium in Critically Ill Adult Patients
Studying Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
- Principal Investigator
- François Marquis, M.D., M.A.Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Est-de-l'Île-de-Montréal
- Intervention
- Melatonin(drug)
- Enrollment
- 30 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada
Collaborators
Maisonneuve-Rosemont Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05713877 on ClinicalTrials.govOther trials for Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT07442162Effects of Melatonin on Excessive Crying in Neonates. A Randomized Controlled Clinical Trial.Al-Hadba university
- RECRUITINGNANCT07345715Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing AdenotonsillectomyTanta University
- RECRUITINGNANCT06093477Studying Melatonin and Recovery in TeensStanford University
- RECRUITINGNANCT05829044Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian RhythmsMassachusetts General Hospital
- RECRUITINGNANCT05107947Light in Frail Elderly - the Effect of a Dynamic Light for Sleep and Circadian RhythmRegion Skane
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04233112Melatonin and Osteogenic Loading on OsteopeniaDuquesne University
- RECRUITINGPHASE3NCT05651347Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth RestrictionMonash University
See all trials for Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome →